| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,937,013 | 2,665,332 | 2,237,586 | | Cost of Revenue | 634,744 | 562,401 | 502,638 | | | Gross Profit | 2,302,269 | 2,102,931 | 1,734,948 | | | Operating Expenses | | Research Development | 208,952 | 182,483 | 140,371 | | Selling General and Administrative | 1,456,834 | 1,313,810 | 1,075,844 | | Non Recurring | 2,996,000 |
-
| 47,000 | | Others | 69,436 | 77,569 | 120,404 | | | | Total Operating Expenses | 4,731,222 |
-
| 1,383,619 | | | | Operating Income or Loss | (2,428,953) | 529,069 | 351,329 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,767) | 23,425 | 50,835 | | Earnings Before Interest And Taxes | (2,442,720) | 549,880 | 402,164 | | Interest Expense | 71,984 | 52,896 | 17,266 | | Income Before Tax | (2,514,704) | 496,984 | 384,898 | | Income Tax Expense | 5,966 | 203,114 | 139,451 | | Minority Interest | 2,907 | 1,994 | (513) | | | | Net Income From Continuing Ops | (2,517,763) | 295,864 | 244,934 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,517,763) | 295,864 | 244,934 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,517,763) | $295,864 | $244,934 |
|
0.29% Nasdaq 
Income Statement
